The use of an invitro 3D melanoma model to predict invivo plasmid transfection using electroporation

Biomaterials

Volumn 33, Issue 10, 2012, Pages 3036-3046

  Marrero, Bernadette ^a   Heller, Richard ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b OLD DOMINION UNIVERSITY   (United States)

Author keywords

3D tumor model; Bioreactor; Electroporation; Gene transfer; Melanoma

Indexed keywords

3D MODELS; CANCER THERAPY; CELLULAR RESPONSE; CLINICAL TRIAL; DELIVERY TECHNIQUES; ELECTRIC FIELD STRENGTH; ELECTROPORATION; GENE DELIVERY; GREEN FLUORESCENT PROTEIN; IN-VITRO; IN-VIVO; MELANOMA; PLASMID TRANSFECTION; PULSE LENGTH; TUMOR CELLS; TUMOR MODELS;

ANIMALS; BIOREACTORS; CELLS; DERMATOLOGY; DNA; ELECTRIC FIELDS; GENE THERAPY; GENE TRANSFER; MOLECULAR BIOLOGY; ONCOLOGY; TUMORS;

THREE DIMENSIONAL;

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 15;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRIC FIELD; ELECTRODE; ELECTROPORATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TUMOR CELL; TUMOR MODEL; ANIMAL; C57BL MOUSE; DISEASE MODEL; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; METABOLISM; METHODOLOGY; MULTICELLULAR SPHEROID; PATHOLOGY; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ELECTRODES; ELECTROPORATION; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; INTERLEUKIN-15; MELANOMA; MICE; MICE, INBRED C57BL; PLASMIDS; SPHEROIDS, CELLULAR; TRANSFECTION;

EID: 84856250097     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.12.049     Document Type: Article

References (38)

1. Becker J.L., Blanchard D.K. Characterization of primary breast carcinomas grown in three-dimensional cultures. JSurg Res 2007, 142:256-262.
2. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610.
3. Pickl M., Ries C.H. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 2009, 28:461-468.
4. Schoop V.M., Mirancea N., Fusenig N.E. Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. JInvest Dermato 1999, 112:343-353.
5. Hutmacher D.W., Loessner D., Rizzi S., Kaplan D.L., Mooney D.J., Clements J.A. Can tissue engineering concepts advance tumor biology research?. Trends Biotechnol 2010, 28:125-133.
6. Wasungu L., Escoffre J.M., Valette A., Teissie J., Rols M.P. A3D invitro spheroid model as a way to study the mechanisms of electroporation. Int J Pharm 2009, 379(2):278-284.
7. Chopinet L., Wasungu L., Rols M.P. First explanations for differences in electrotransfection efficiency invitro and invivo using spheroid model. Int JPharm 2011 Apr 28, [Epub ahead of print].
8. Haass N.K., Smalley K.S., Li L., Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 2005, 18:150-159.
9. Smalley K.S., Brafford P.A., Herlyn M. Selective evolutionary pressure from the tissue microenvironment drives tumor progression. Semin Cancer Biol 2005, 15:451-459.
10. Marrero B., Messina J.L., Heller R. Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma. InVitro Cell Dev Biol Anim 2009, 45:523-534.
11. Deyrieux A.F., Wilson V.G. Invitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology 2007, 54:77-83.
12. Szell M., Bata-Csorgo Z., Koreck A., Pivarcsi A., Polyanka H., Szeg C., et al. Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin. JInvest Dermatol 2004, 123:537-546.
13. Tajima S., Ura-Ishiko A., Hayashi A. Melanogenesis, biosynthetic phenotype of fibronectin and collagen, and migrating activity in cloned B16 mouse melanoma cells. JDermatol Sci 1996, 12:24-30.
14. Gaggioli C., Deckert M., Robert G., Abbe P., Batoz M., Ehrengruber M.U., et al. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene 2005, 24:1423-1433.
15. Ong S.M., Zhao Z., Arooz T., Zhao D., Zhang S., Du T., et al. Engineering a scaffold-free 3D tumor model for invitro drug penetration studies. Biomaterials 2010, 31:1180-1190.
16. Kelm J.M., Timmins N.E., Brown C.J., Fussenegger M., Nielsen L.K. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 2003, 83(2):173-180.
17. Feder-Mengus C., Ghosh S., Reschner A., Martin I., Spagnoli G.C. New dimensions in tumor immunology: what does 3D culture reveal?. Trends Mol Med 2008, 14:333-340.
18. Smalley K.S., Brafford P., Haass N.K., Brandner J.M., Brown E., Herlyn M. Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am JPathol 2005, 166:1541-1554.
19. Dongari-Bagtzoglou A., Kashleva H. Development of a highly reproducible three-dimensional organotypic model of the oral mucosa. Nat Protoc 2006, 1:2012-2018.
20. Hsu M.Y., Meier F.E., Nesbit M., Hsu J.Y., Van Belle P., Elder D.E., et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am JPathol 2000, 156:1515-1525.
21. Smalley K.S. Apivotal role for ERK in the oncogenic behaviour of malignant melanoma?. Int J Cancer 2003, 104:527-532.
22. Heller L.C., Heller R. Invivo electroporation for genetherapy. Hum Gene Ther 2006, 17(9):890-897.
23. Heller L.C., Jaroszeski M.J., Coppola D., McCray A.N., Hickey J., Heller R. Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode. Gene Ther 2007, 14(3):275-280.
24. Gilbert R.A., Jaroszeski M.J., Heller R. Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1997, 1334(1):9-14.
25. Cheng C., Tennenbaum T., Dempsey P.J., Coffey R.J., Yuspa S.H., Dlugosz A.A. Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes, and transforming growth factor alpha mediates the induction of keratin 8 by the v-rasHa oncogene. Cell Growth Differ 1993, 4:317-327.
26. Kuwahara M., Hatoko M., Tada H., Tanaka A. E-cadherin expression in wound healing of mouse skin. JCutan Pathol 2001, 28:191-199.
27. Boelsma E., Verhoeven M.C., Ponec M. Reconstruction of a human skin equivalent using a spontaneously transformed keratinocyte cell line (HaCaT). JInvest Dermatol 1999, 112:489-498.
28. Stoler A.B., Stenback F., Balmain A. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. JCell Biol 1993, 122:1103-1117.
29. Wang R., Xu J., Juliette L., Castilleja A., Love J., Sung S.Y., et al. Three-dimensional co-culture models to study prostate cancer growth, progression, and metastasis to bone. Semin Cancer Biol 2005, 15:353-364.
30. Tang A., Eller M.S., Hara M., Yaar M., Hirohashi S., Gilchrest B.A. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes invitro. JCell Sci 1994, 107:983-992.
31. Delehedde M., Cho S.H., Hamm R., Brisbay S., Ananthaswamy H.N., Kripke M., et al. Impact of Bcl-2 and Ha-ras on keratinocytes in organotypic culture. JInvest Dermatol 2001, 116:366-373.
32. Lemaitre G., Lamartine J., Pitaval A., Vaigot P., Garin J., Bouet S., et al. Expression profiling of genes and proteins in HaCaT keratinocytes: proliferating versus differentiated state. JCell Biochem 2004, 93:1048-1062.
33. Lee S.B., Schramme A., Doberstein K., Dummer R., Abdel-Bakky M.S., Keller S., et al. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. JInvest Dermatol 2010, 130:763-773.
34. Lucas M.L., Heller R. Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther 2001, 3(1):47-53.
35. Lucas M.L., Heller L., Coppola D., Heller R. IL-12 plasmid delivery by invivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002, 5:668-675.
36. Budagian V., Bulanova E., Paus R., Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev 2006, 17:259-280.
37. Ruckert R., Asadullah K., Seifert M., Budagian V.M., Arnold R., Trombotto C., et al. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?. JImmunol 2000, 165:2240-2250.
38. Maas-Szabowski N., Starker A., Fusenig N.E. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-alpha. JCell Sci 2003, 116:2937-2948.